PicnicHealth

PicnicHealth is a patient-centered health technology company that provides patients with unprecedented access to and control over their medical records. The company collects and organizes complete medical data from all care sites a patient has visited, including records, lab results, imaging scans, and patient-reported outcomes. This data is then made available to patients through an online platform, allowing them to conveniently access their entire medical history. With patient consent, PicnicHealth leverages this comprehensive real-world data to build customized datasets for life sciences companies and research institutions across various therapeutic areas such as neurology, hematology, and rare diseases. The company utilizes advanced machine learning and human curation to structure the medical data, enabling researchers to gain insights into the real-world patient journey and accelerate the development of new treatments. In October 2023, PicnicHealth acquired AllStripes, a platform focused on gathering clinical evidence for rare disease patients, further expanding its capabilities in this area.

Key customers and partnerships

In April 2023, PicnicHealth announced partnerships with CureDuchenne, a nonprofit organization dedicated to finding a cure for Duchenne muscular dystrophy, and Roche/Genentech, a leading biopharmaceutical company. The CureDuchenne partnership allows patients to contribute their medical records to a data-integrated biobank, facilitating research efforts. Meanwhile, the Roche/Genentech collaboration involves developing comprehensive datasets for neurological diseases like Alzheimer's, Huntington's, and myasthenia gravis to support the companies' research initiatives.

Another notable partnership was established in November 2022 with Bristol Myers Squibb. PicnicHealth provided consented real-world patient data to supplement Bristol Myers Squibb's DISCOVER-HCM Registry, a study on obstructive hypertrophic cardiomyopathy patients receiving treatment.

In August 2023, PicnicHealth partnered with AstraZeneca to create a registry generating longitudinal real-world data from breast cancer patients in the US. This initiative aims to advance oncology research through robust patient-centered datasets.